Tyra Biosciences, Inc. (TYRA)
36.69
-0.44
(-1.18%)
USD |
NASDAQ |
Apr 09, 16:00
36.00
-0.69
(-1.88%)
Pre-Market: 08:14
Tyra Biosciences Shareholders Equity (Quarterly) : 259.18M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 715.24M |
| Entrada Therapeutics, Inc. | 306.13M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
| Ionis Pharmaceuticals, Inc. | 489.09M |
| Agios Pharmaceuticals, Inc. | 1.193B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 284.05M |
| Total Liabilities (Quarterly) | 24.87M |
| Debt to Equity Ratio | 0.0224 |
| Current Ratio | 14.67 |
| Net Debt Paydown Yield | 0.01% |